{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.0/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Erythromycin",
            "Path": "https://raw.githubusercontent.com/AndreDlm/Erythromycin-Model/master/Erythromycin.json",
            "BuildingBlocks": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "mg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "mg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "mg/l",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Erythromycin",
                "Simulation": "IV_1000mg_Huppertz2011",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_125mg_Austin1980",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_125mg_Sun2010",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_250mg_3min_Austin1980",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_250mg_Austin1980",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_300mg_Pasic1987",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_500mg_Austin1980",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_500mg_Barre1987",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "IV_900mg_Austin1980",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "1000mg_Josefsson1982a_pellets",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Birkett1990",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Josefsson1982a_pellets",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Josefsson1982a_pellets",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Kivistö1997_pellets_MD",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Schreiner1984_pellets",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Yakatan1980_base_MD",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_DiSanto1981",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Kroboth1982",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Posti1982_E",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "1000mg_Miglioli1990_MD",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Yakatan1980_stearate",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "250mg_Yakatan1980_stearate_MD",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Iliopoulou1982_MD",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Josefsson1982a",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Kavi1988",
                "SectionId": 332
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Malmborg1978_MD",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Posti1983_A1",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Posti1983_A2/RN",
                "SectionId": 331
            },
            {
                "Project": "Erythromycin",
                "Simulation": "500mg_Schreiner1984_stearate",
                "SectionId": 332
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plot for concentration in plasma",
                "SectionId": 32,
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "IV (model building)",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_125mg_Sun2010",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Sun 2010 - Subjects with normal renal function - Erythromycin - IV - 125 mg - Plasma - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_250mg_3min_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 250 mg over 3 min (Regimen 1) - Erythromycin - IV - 250 mg - Serum - agg. (n=24)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_300mg_Pasic1987",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Pasic 1987 - Without oral theophylline co-administration - Erythromycin - IV - 300 mg - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_500mg_Barre1987",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Barre 1987 - 500 mg over 30 min, total concentrations - Erythromycin - IV - 500 mg - Serum - agg. (n=6)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_500mg_Barre1987",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Barre 1987 - 500 mg over 30 min, unbound concentrations - Erythromycin - IV - 500 mg - Serum - agg. (n=6)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, stearate (model building)",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "1000mg_Miglioli1990_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Miglioli 1990 - First dose, young subjects - Erythromycin - PO - 1 g - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "1000mg_Miglioli1990_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Miglioli 1990 - Seventh dose, young subjects - Erythromycin - PO - 1 g - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Yakatan1980_stearate",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yakatan 1980 - Stearate, single dose - Erythromycin - PO - 250 mg - Serum - agg. (n=8)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Yakatan1980_stearate_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yakatan 1980 - Stearate, five doses, every 6 h - Erythromycin - PO - 250 mg - Serum - agg. (n=24)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Malmborg1978_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malmborg 1978 - Single dose after overnight fast - Erythromycin - PO - 500 mg - Plasma - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Malmborg1978_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malmborg 1978 - Single dose before standardized breakfast - Erythromycin - PO - 500 mg - Plasma - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Malmborg1978_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malmborg 1978 - Day 7, every 8 h - Erythromycin - PO - 500 mg - Plasma - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1983_A1",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation A1 (film-coated tabet, ery stearate), fasted - Erythromycin - PO - 500 mg - Serum - agg. (n=15)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1983_A2/RN",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation A2 (film-coated tabet, ery stearate), study 2 - Erythromycin - PO - 500 mg - Serum - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1983_A2/RN",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation RN (film-coated tabet, ery stearate), study 2 - Erythromycin - PO - 500 mg - Serum - agg. (n=12)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "PO enteric coated tablet, base (model building)",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_DiSanto1981",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DiSanto 1981 - Overnight fast, enteric-coated erythromycin tablets (study 1) - Erythromycin - PO - 500 mg - Serum - agg. (n=21)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_DiSanto1981",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "DiSanto 1981 - 2h fast, enteric-coated erythromycin tablets (study 2) - Erythromycin - PO - 500 mg - Serum - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Posti1982_E",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Posti 1983 - Formulation E (enteric-coated tablets, ery base), fasted - Erythromycin - PO - 500 mg - Serum - agg. (n=15)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "PO enteric coated capsule, base pellets (model building)",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Birkett1990",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Birkett 1990 - 250 mg erythromycin, single dose - Erythromycin - PO - 250 mg - Plasma - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Birkett1990",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Birkett 1990 - 250 mg erythromycin, multiple dose - Erythromycin - PO - 250 mg - Plasma - agg. (n=12)",
                                "Color": "#1f78b4"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Kivistö1997_pellets_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kivistö 1997 - with Perpetrator (Erythromycin) - Erythromycin - PO - 500 mg - Plasma - agg. (n=8)",
                                "Color": "#1f78b4"
                            }
                        ]
                    },
                    {
                        "Caption": "IV",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_1000mg_Huppertz2011",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Huppertz 2011 - Treatment group, erythromycin - Erythromycin - IV - 1000 mg - Plasma - agg. (n=12)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_125mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 125 mg over 15 min (Regimen 2) - Erythromycin - IV - 125 mg - Serum - agg. (n=5)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_250mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 250 mg over 15 min (Regimen 2) - Erythromycin - IV - 250 mg - Serum - agg. (n=5)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_500mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 500 mg over 15 min (Regimen 2) - Erythromycin - IV - 500 mg - Serum - agg. (n=4)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "IV_900mg_Austin1980",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Austin 1980 - 900 mg over 15 min (Regimen 2) - Erythromycin - IV - 900 mg - Serum - agg. (n=3)",
                                "Color": "#b2df8a"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, stearate",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Iliopoulou1982_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Iliopoulou 1982 - fourth day, before theophylline administration - Erythromycin - PO - 500 mg - Serum - agg. (n=6)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Josefsson1982a",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin stearate 500 mg (base equivalent) - Erythromycin - PO - 500 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Kavi1988",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kavi 1988 - Serum levels - Erythromycin - PO - 500 mg - Serum - agg. (n=6)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_stearate",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part I, stearate tablet - Erythromycin - PO - 500 mg - Serum - agg. (n=14)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_stearate",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part II, stearate tablet - Erythromycin - PO - 500 mg - Serum - agg. (n=10)",
                                "Color": "#b2df8a"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, base",
                        "Symbol": "Diamond",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Yakatan1980_base_MD",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Yakatan 1980 - Base, five doses, every 6 h - Erythromycin - PO - 250 mg - Serum - agg. (n=24)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Kroboth1982",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Kroboth 1982 - Normal subjects - Erythromycin - PO - 500 mg - Serum - agg. (n=6)",
                                "Color": "#b2df8a"
                            }
                        ]
                    },
                    {
                        "Caption": "PO film-coated tablet, base pellets",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Erythromycin",
                                "Simulation": "1000mg_Josefsson1982a_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin base 1000 mg - Erythromycin - PO - 1000 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "250mg_Josefsson1982a_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin base 250 mg - Erythromycin - PO - 250 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Josefsson1982a_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Josefsson 1982a - erythromycin base 500 mg - Erythromycin - PO - 500 mg - Serum - agg. (n=23)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part I, base (enteric-coated pellets) - Erythromycin - PO - 500 mg - Serum - agg. (n=14)",
                                "Color": "#b2df8a"
                            },
                            {
                                "Project": "Erythromycin",
                                "Simulation": "500mg_Schreiner1984_pellets",
                                "Output": "Organism|PeripheralVenousBlood|Erythromycin|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Schreiner 1984 - Part II, base (enteric-coated pellets) - Erythromycin - PO - 500 mg - Serum - agg. (n=10)",
                                "Color": "#b2df8a"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Name": "Erythromycin",
            "Project": "Erythromycin",
            "Type": "Compound",
            "SectionId": 31
        },
        {
            "Name": "Erythromycin_Weibull_enteric-coated-pellets",
            "Project": "Erythromycin",
            "Type": "Formulation",
            "SectionId": 31
        },
        {
            "Name": "Erythromycin_Weibull_enteric-coated-tablet",
            "Project": "Erythromycin",
            "Type": "Formulation",
            "SectionId": 31
        },
        {
            "Name": "Erythromycin_Weibull_filmtablet",
            "Project": "Erythromycin",
            "Type": "Formulation",
            "SectionId": 31
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "1 Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "2 Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Title": "2.1 Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Id": 22,
                    "Title": "2.2 Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Id": 23,
                    "Title": "2.3 Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Id": 3,
            "Title": "3 Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Id": 31,
                    "Title": "3.1 Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Id": 32,
                    "Title": "3.2 Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Id": 33,
                    "Title": "3.3: Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "3.3.1 Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Id": 332,
                            "Title": "3.3.2 Model Verification",
                            "Content": "Content/Concentration_time_profiles_verification.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 4,
            "Title": "4 Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Id": 5,
            "Title": "5 References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}
